Citation Information
Acknowledging RI-INBRE Support
As a condition for accepting research support, either directly through a research or training award from the RI-INBRE Program, or through the use of its Core Facilities or services, the beneficiaries are required to acknowledge the RI-INBRE grant in their scientific meeting abstracts and publications along with a disclaimer.
Compliance with NIH’s Public Access Policy is required for all publications (see below).
Grant citing in all abstracts/presentations, and publications by investigators, mentors, students, and SURF mentors, and in media articles:
“Research reported in this [publication, release] was supported (fully or in part, as appropriate) by the Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103430.”
CRCF & Molecular Informatics users citing:
“Research was made possible by the use of [equipment and/or services, as appropriate] available through the Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103430 through the Centralized Research Core facility and/or the Molecular Informatics Core (RRID:SCR_017685).” *
Reporting in Biosketch, Curriculum Vitae, and Other Support:
P20GM103430 Cho, Bongsup P. (PI) [Award date range MM/DD/YY-MM/DD/YY]
[Type of Award, example CR, ECD, SURF] RI-INBRE: [Title of subaward]
Role: Subproject PI
Compliance with NIH Public Access Policy
All publications must be compliant with the NIH Public Access Policy. This includes submission of your full-text manuscript to PubMed Central (PMC). Submission to PMC may be done automatically through the journal you have submitted to or it may require direct submission. Please review the resources below:
Published Manuscripts
Please provide one set of the abstracts and accepted/published manuscripts and PMID# of each manuscript, acknowledging the RI-INBRE grant, to: RI-INBRE Program office, 495E, College of Pharmacy, University of Rhode Island, 7 Greenhouse Road, Kingston, RI 02881, or by e-mail to: RI-INBRE.
All such abstracts/presentations, and publications are reported to NIH in our Annual Progress Report which is due at the end of February each year.
Failure to comply with the above requirements will result in termination of future financial support from the RI-INBRE Program and/or access to its Core Facilities and services.
Your cooperation in this matter is greatly appreciated.
*RRID = Research Resource Identifier (aims to promote research resource identification, discovery, and reuse)